HPR12 Assessment of the French National Experimentation for Incentivising Hospital Prescriptions of Adalimumab Biosimilars Delivered in Retail Pharmacies
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.938
https://www.valueinhealthjournal.com/article/S1098-3015(22)01139-1/fulltext
Section Title :
Section Order :
10849
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01139-1&doi=10.1016/j.jval.2022.04.938